25.81 USD
↗ 0.26 (1.02%)AT CLOSE (03:59 PM EDT)
vTv Therapeutics Inc. Class A Common Stock
VTVTNASDAQ • USD
25.97
↗ 0.16 (0.60%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
25.97
↗ 0.16 (0.60%)
Market: CLOSED
vTv Therapeutics Inc. Class A Common Stock (VTVT) is currently trading at $26.13. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, VTVT appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$26.14
High?$26.56
Low?$25.68
Prev. Close?$25.55
Volume?15.1K
Avg. Volume?32.4K
VWAP?$26.12
Rel. Volume?0.47x
Bid / Ask
Bid?$21.26 × 100
Ask?$31.39 × 100
Spread?$10.13
Midpoint?$26.33
Valuation & Ratios
Market Cap?101.0M
Shares Out?3.9M
Float?1.5M
Float %?37.6%
P/E Ratio?N/A
P/B Ratio?1.28
EPS?-$1.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.
Employees
26
Market Cap
101.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-07-30
Address
3980 PREMIER DR
HIGH POINT, NC 27265
Phone: 336-841-0300
HIGH POINT, NC 27265
Phone: 336-841-0300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?68
Momentum?50
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?2.89Grey
Confidence?49%Low
Short InterestHigh
Short % of Float?9.68%Elevated
Short Interest?143.4K
Days to Cover?5.7
Free Float1.5M
Avg Daily Volume25.3K
Settlement Date2026-10-15
Financial Health
Current Ratio?12.48Strong
Quick Ratio?12.48Strong
Cash Ratio?12.35Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.28CHEAP▾
Peers100
S&P92
P/S?2.74CHEAP▾
Peers100
S&P54
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
S&P97
EV/Sales?0.39CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-6.1%WEAK▾
S&P10
ROA?-5.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-16762000
Enterprise Value?$14.4M
Fundamentals ratios updated end of day